Payment card signal characterization methods and circuits

Details for Australian Patent Application No. 2005274949 (hide)

Owner MasterCard International Incorporated

Inventors Van De Velde, Eddy Lodewijk Hortensia; Garrett, Duncan; Smets, Patrick

Agent Freehills

Pub. Number AU-A-2005274949

PCT Pub. Number WO2006/020072

Priority 60/588,270 15.07.04 US

Filing date 15 July 2005

Wipo publication date 23 February 2006

International Classifications

G06K 7/08 (2006.01) Methods or arrangements for sensing record carriers - by means detecting the change of an electrostatic or magnetic field, e.g. by detecting change of capacitance between electrodes

G06K 5/00 (2006.01) Methods or arrangements for verifying the correctness of markings on a record carrier

G06K 19/06 (2006.01) Record carriers for use with machines and with at least a part designed to carry digital markings - characterised by the kind of the digital marking, e.g. shape, nature, code

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/020072 Priority application(s): WO2006/020072

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274950-Method and system using a bitmap for passing contactless payment card transaction variables in standardized data formats

2005274948-Vaccines against aids comprising CMV/ R-nucleic acid constructs